Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma
Clinical trial NCT04059562 · COMPLETED
Trial details
- NCT number
- NCT04059562
- Sponsor
- Heinrich-Heine University, Duesseldorf
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2024-01-08
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.